Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol

RO Day, GG Graham, M Hicks, AJ McLachlan… - Clinical …, 2007 - Springer
Allopurinol is the drug most widely used to lower the blood concentrations of urate and,
therefore, to decrease the number of repeated attacks of gout. Allopurinol is rapidly and …

Clinical pharmacokinetics of allopurinol

GAC Murrell, WG Rapeport - Clinical pharmacokinetics, 1986 - Springer
Allopurinol is a widely used drug in the management of hyperuricaemia. It is rapidly and
extensively absorbed following oral administration. The major and active metabolite …

Kinetics of allopurinol after single intravenous and oral doses: noninteraction with benzbromarone and hydrochlorothiazide

H Breithaupt, M Tittel - European Journal of Clinical Pharmacology, 1982 - Springer
An high-pressure liquid chromatographic method was used to measure allopurinol and
oxipurinol in plasma and urine in 6 healthy volunteers after a single intravenous or oral dose …

Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects

Turnheim, Krivanek, Oberbauer - British journal of clinical …, 1999 - Wiley Online Library
Aims The prevalence of hyperuricaemia and gout increases with age as does the incidence
of adverse effects to allopurinol, the major uric acid lowering drug. The present study was …

Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.

RO Day, JO Miners, DJ Birkett… - British journal of …, 1988 - Wiley Online Library
1. Allopurinol usage in 50 patients of a city teaching hospital was surveyed. 2. The plasma
concentrations of oxipurinol and uric acid and the urinary production of uric acid were …

Allopurinol kinetics

K Hande, E Reed, B Chabner - Clinical Pharmacology & …, 1978 - Wiley Online Library
A spectrophotometric assay for measuring allopurinol and oxipurinol has been developed
which can detect as little as 5× 10− 8 M of each in serum and urine. With this assay, serum …

Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects

S Graham, RO Day, H Wong… - British journal of …, 1996 - Wiley Online Library
1 Eight healthy subjects received 50, 100, 300, 600 and 900 mg allopurinol daily for 1 week
each, in random order with 1 week separating each treatment period. The pre‐dose plasma …

Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency

KR Hande, RM Noone, WJ Stone - The American journal of medicine, 1984 - Elsevier
A life-threatening toxicity syndrome consisting of an erythematous, desquamative skin rash,
fever, hepatitis, eosinophilia, and worsening renal function in 78 patients receiving …

Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout

SL Stocker, GG Graham, AJ McLachlan… - The Journal of …, 2011 - jrheum.org
Objective. To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …

The optimal use of allopurinol: an audit of allopurinol use in South Auckland

L Stamp, P Gow, K Sharples… - Australian and New …, 2000 - Wiley Online Library
Background: Gout is a common and challenging problem in South Auckland, New Zealand.
Allopurinol is widely used but urate reduction remains unsatisfactory. Allopurinol dosing …